NRNP 6552 Womens health midterm Correctly Verified Questions And
w2 w2 w2 w2 w2 w2 w2 w2
Answers
w2
Question 1 w2 0/1
A Lower
w 2
.
B Media
w2
n
.w 2
C Highe
w2
r
.w 2
D Absen
w2
t
.w 2
Question 2 w2 w 2 1/1
A A speculum exam
w 2 w 2 w 2
.
B A bimanual exam
w 2 w 2 w 2
.
C A pap smear
w 2 w 2 w 2
.
D A transvaginal
w2
w 2
ultrasound
.
Question 3 w2 1/1
A Challenging
w 2
w 2 w 2 behaviors w 2 w 2 in w 2 w 2 others w 2 w 2 that w 2 w 2 promote
violence
.
B Engaging in
w 2
w 2 w 2 healthy w 2 professional w 2 and w 2 personal
relationships
.
C Learning to identify
w 2
w 2 w 2 w 2 w 2 risk w 2 factors w 2 w 2 for w 2 sexually w 2 w 2 abusive
behaviors
.
D B and C
w2 w 2 w 2
.
E A, B, and C
w 2 w 2 w 2 w 2
.
Question 4 w2 1/1
,NRNP 6552 Womens health midterm Correctly Verified Questions And
w2 w2 w2 w2 w2 w2 w2 w2
Answers
w2
A 6-12 w 2
months
.
B 6-18
w 2
months
.
C 12-24 w 2
months
.
D 3-5 years
w2 w 2
.
Question 5 w2 1/1
Barriers w 2 i for
w2 w 2 i providers
w2 w 2 i related
w2 w 2 i tow
2 w 2 i intimate
w2 w 2 i partner
w2 w 2 i violence
w2 w 2 iscreening w 2 i include:
w2
A Discomfort with the topic
w 2 w 2 w 2 w 2
.
B Having too much power that
w 2
w 2 w 2 w 2 w 2 w 2 might w 2 be
intimidating
.
C Time constraints
w 2 w 2
.
D A and C
w2 w 2 w 2
.
E A, B, and C
w 2 w 2 w 2 w 2
.
Question 6 w2 1/1
Hirsutism w 2 i is
w2 w 2 i defined
w2 w 2 i as:
w2
A w 2
Excessive w 2 terminal w 2 hair w 2 loss w 2 in
women
.
B w 2 Excessive w 2 nail w 2 growth w 2 in w 2 women
.
C w 2 Brittle w 2 nail w 2 growth w 2 in w 2 women
.
D w 2
Excessive w 2 w 2 terminal w 2 w 2 hair w 2 w 2 growth w 2 w 2 in
women
.
Question 7 w2 0/1
A i pharmacologic
w 2 w2 w 2 i treatment
w2 w 2 i for
w2 w 2 i patients
w2 w 2 i with
w2 w 2 i Hydradenitis
w2 w 2 i Suppurativa
w2 w 2 i (HI)
w2 w 2 i may
w2 w 2 i
include
w2 w 2
A Clindamycin
w2
.
B Minocycline
w2
.
C Metformin
w 2
, NRNP 6552 Womens health midterm Correctly Verified Questions And
w2 w2 w2 w2 w2 w2 w2 w2
Answers
w2
.
D All of the
w2
w 2 w 2
above
.
Question 8 w2 1/1
A There are too many studies involving women
w 2 w 2 w 2 w 2 w 2 w 2 w 2
.
B Most of the research is qualitative, which limits the applicability
w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2
.
C For many years, studies were done primarily on men with the
w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 findings
being
w 2
w 2 w 2
generalized to women
.
w 2 w 2
D None w 2 w 2 of w 2 the w 2 above
.
Question 9 w2 w 2 1/1
Most w 2 i malignancies
w2 w 2 i inw2 w 2 i breast
w2 w 2 i tissue
w2 w 2 i occur
w2 w 2 i in:
w2
A The areolar area
w 2 w 2 w 2
.
B The upper outer
w 2
w 2 w 2
quadrant
.
C The lower outer
w 2
w 2 w 2
quadrant
.
D None of the above
w 2 w 2 w 2 w 2
.
Question 10 w2 0/1
On ivaginal
w 2 w 2 i exam
w2 w 2 i you
w2 w 2 i find
w
2 w 2 i that
w2 w 2 i Polly’s
w2 w 2 i cervix iis
w2 w 2 w 2 i in ithe
w
2 w 2 w 2 i most i common
w2 w 2 w
2 w 2 iposition,
w
2 w 2 i
which iis:
w2 w 2 w
2
A Anterior w2
.
B Midline w2
.
C Posteriorw2
.
D Retroflex
w2
ed
. w 2
w2 w2 w2 w2 w2 w2 w2 w2
Answers
w2
Question 1 w2 0/1
A Lower
w 2
.
B Media
w2
n
.w 2
C Highe
w2
r
.w 2
D Absen
w2
t
.w 2
Question 2 w2 w 2 1/1
A A speculum exam
w 2 w 2 w 2
.
B A bimanual exam
w 2 w 2 w 2
.
C A pap smear
w 2 w 2 w 2
.
D A transvaginal
w2
w 2
ultrasound
.
Question 3 w2 1/1
A Challenging
w 2
w 2 w 2 behaviors w 2 w 2 in w 2 w 2 others w 2 w 2 that w 2 w 2 promote
violence
.
B Engaging in
w 2
w 2 w 2 healthy w 2 professional w 2 and w 2 personal
relationships
.
C Learning to identify
w 2
w 2 w 2 w 2 w 2 risk w 2 factors w 2 w 2 for w 2 sexually w 2 w 2 abusive
behaviors
.
D B and C
w2 w 2 w 2
.
E A, B, and C
w 2 w 2 w 2 w 2
.
Question 4 w2 1/1
,NRNP 6552 Womens health midterm Correctly Verified Questions And
w2 w2 w2 w2 w2 w2 w2 w2
Answers
w2
A 6-12 w 2
months
.
B 6-18
w 2
months
.
C 12-24 w 2
months
.
D 3-5 years
w2 w 2
.
Question 5 w2 1/1
Barriers w 2 i for
w2 w 2 i providers
w2 w 2 i related
w2 w 2 i tow
2 w 2 i intimate
w2 w 2 i partner
w2 w 2 i violence
w2 w 2 iscreening w 2 i include:
w2
A Discomfort with the topic
w 2 w 2 w 2 w 2
.
B Having too much power that
w 2
w 2 w 2 w 2 w 2 w 2 might w 2 be
intimidating
.
C Time constraints
w 2 w 2
.
D A and C
w2 w 2 w 2
.
E A, B, and C
w 2 w 2 w 2 w 2
.
Question 6 w2 1/1
Hirsutism w 2 i is
w2 w 2 i defined
w2 w 2 i as:
w2
A w 2
Excessive w 2 terminal w 2 hair w 2 loss w 2 in
women
.
B w 2 Excessive w 2 nail w 2 growth w 2 in w 2 women
.
C w 2 Brittle w 2 nail w 2 growth w 2 in w 2 women
.
D w 2
Excessive w 2 w 2 terminal w 2 w 2 hair w 2 w 2 growth w 2 w 2 in
women
.
Question 7 w2 0/1
A i pharmacologic
w 2 w2 w 2 i treatment
w2 w 2 i for
w2 w 2 i patients
w2 w 2 i with
w2 w 2 i Hydradenitis
w2 w 2 i Suppurativa
w2 w 2 i (HI)
w2 w 2 i may
w2 w 2 i
include
w2 w 2
A Clindamycin
w2
.
B Minocycline
w2
.
C Metformin
w 2
, NRNP 6552 Womens health midterm Correctly Verified Questions And
w2 w2 w2 w2 w2 w2 w2 w2
Answers
w2
.
D All of the
w2
w 2 w 2
above
.
Question 8 w2 1/1
A There are too many studies involving women
w 2 w 2 w 2 w 2 w 2 w 2 w 2
.
B Most of the research is qualitative, which limits the applicability
w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2
.
C For many years, studies were done primarily on men with the
w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 w 2 findings
being
w 2
w 2 w 2
generalized to women
.
w 2 w 2
D None w 2 w 2 of w 2 the w 2 above
.
Question 9 w2 w 2 1/1
Most w 2 i malignancies
w2 w 2 i inw2 w 2 i breast
w2 w 2 i tissue
w2 w 2 i occur
w2 w 2 i in:
w2
A The areolar area
w 2 w 2 w 2
.
B The upper outer
w 2
w 2 w 2
quadrant
.
C The lower outer
w 2
w 2 w 2
quadrant
.
D None of the above
w 2 w 2 w 2 w 2
.
Question 10 w2 0/1
On ivaginal
w 2 w 2 i exam
w2 w 2 i you
w2 w 2 i find
w
2 w 2 i that
w2 w 2 i Polly’s
w2 w 2 i cervix iis
w2 w 2 w 2 i in ithe
w
2 w 2 w 2 i most i common
w2 w 2 w
2 w 2 iposition,
w
2 w 2 i
which iis:
w2 w 2 w
2
A Anterior w2
.
B Midline w2
.
C Posteriorw2
.
D Retroflex
w2
ed
. w 2
